http://dx.doi.org/10.1161/01.CIR.0000083366.33686.11
pubmed: 12860901
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases.
2003-07-22
Article
| Related Files |
|---|
|
Redirect to publisher's version
(publisher's version.url.txt, 52 bytes) |
BACKGROUND: We describe the clinical and morphological patterns of restenosis after sirolimus-eluting stent (SES) implantation. METHODS AND RESULTS: From 121 patients with coronary angiography obtained >30 days after SES implantation, restenosis (diameter stenosis >50%) was identified in 19 patients and 20 lesions (located at the proximal 5-mm segment in 30% or within the stent in 70%). Residual dissection after the procedure or balloon trauma outside the stent was identified in 83% of the proximal edge lesions. Lesions within the stent were focal, and stent discontinuity was identified in some lesions evaluated by intravascular ultrasound. CONCLUSIONS: Sirolimus-eluting stent edge restenosis is frequently associated with local trauma outside the stent. In-stent restenosis occurs as a localized lesion, commonly associated with a discontinuity in stent coverage. Local conditions instead of intrinsic drug-resistance to sirolimus are likely to play a major role in post-SES restenosis.
- Male
- Adult
- Aged
- Female
- Humans
- Follow-Up Studies
- Middle Aged
- Treatment Outcome
- Coronary Angiography
- Ultrasonography, Interventional
- Stents/*adverse effects
- Angioplasty, Transluminal, Percutaneous Coronary
- Blood Vessel Prosthesis Implantation/*adverse effects
- Coronary Restenosis/*diagnosis/*etiology
- Drug Implants/adverse effects
- Immunosuppressive Agents/adverse effects
- Postoperative Complications/diagnosis/etiology
- Registries
- Sirolimus/*adverse effects